Page last updated: 2024-08-26

sr141716 and Peripheral Nervous System Diseases

sr141716 has been researched along with Peripheral Nervous System Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, KL; Dart, MJ; McGaraughty, S; Meyer, MD; Yao, BB1
Calignano, A; Clapper, JR; Duranti, A; Guijarro, A; Hohmann, AG; Mor, M; Moreno-Sanz, G; Piomelli, D; Russo, R; Sanchini, S; Sciolino, NR; Spradley, JM; Tarzia, G; Tontini, A; Vacondio, F1
Chapman, V; Elmes, SJ; Jhaveri, MD; Kendall, DA; Smart, D1
Liu, C; Walker, JM1
Bennett, GJ; Eliav, E; Herzberg, U; Kopin, IJ1
Azami, J; Green, DL; Monhemius, R; Roberts, MH1

Other Studies

6 other study(ies) available for sr141716 and Peripheral Nervous System Diseases

ArticleYear
A CB(2) receptor agonist, A-836339, modulates wide dynamic range neuronal activity in neuropathic rats: contributions of spinal and peripheral CB(2) receptors.
    Neuroscience, 2009, Feb-18, Volume: 158, Issue:4

    Topics: Action Potentials; Animals; Camphanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Ganglia, Spinal; Male; Neurons; Peripheral Nervous System Diseases; Physical Stimulation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Rimonabant; Spinal Cord; Thiazoles

2009
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.
    Nature neuroscience, 2010, Volume: 13, Issue:10

    Topics: Amidohydrolases; Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Cannabinoids; Carrageenan; Chromatography, Liquid; Disease Models, Animal; Drug Administration Routes; Drug Administration Schedule; Endocannabinoids; Enzyme Inhibitors; Escape Reaction; Ethylene Glycols; Feeding Behavior; Formaldehyde; Gene Expression Regulation; Hyperalgesia; Indoles; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Mice, Knockout; Monoacylglycerol Lipases; Motor Activity; Oncogene Proteins v-fos; Pain; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Piperidines; Polyunsaturated Alkamides; PPAR alpha; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Sciatica; Spinal Cord; Statistics, Nonparametric; Time Factors; Tissue Distribution; Tritium

2010
Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain.
    The European journal of neuroscience, 2004, Volume: 20, Issue:9

    Topics: Action Potentials; Animals; Camphanes; Cannabinoids; Carrageenan; Disease Models, Animal; Inflammation; Ligation; Male; Neural Inhibition; Neuralgia; Nociceptors; Peripheral Nervous System Diseases; Physical Stimulation; Piperidines; Posterior Horn Cells; Pyrazoles; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Sensory Receptor Cells; Spinal Nerves

2004
Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain.
    Journal of neurophysiology, 2006, Volume: 96, Issue:6

    Topics: Analgesics; Animals; Behavior, Animal; Benzoxazines; Camphanes; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Dose-Response Relationship, Drug; Electrophysiology; Hot Temperature; Hyperalgesia; In Vitro Techniques; Morpholines; Naphthalenes; Neurons; Nociceptors; Pain; Peripheral Nervous System Diseases; Piperidines; Posterior Horn Cells; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Spinal Cord

2006
The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain.
    Neuroscience letters, 1997, Jan-17, Volume: 221, Issue:2-3

    Topics: Analgesics, Non-Narcotic; Animals; Benzoxazines; Cannabinoids; Hot Temperature; Hyperalgesia; Injections, Intraperitoneal; Male; Morpholines; Naphthalenes; Pain; Peripheral Nervous System Diseases; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant

1997
CB1 receptor mediated analgesia from the Nucleus Reticularis Gigantocellularis pars alpha is activated in an animal model of neuropathic pain.
    Brain research, 2001, Jul-20, Volume: 908, Issue:1

    Topics: Analgesia; Analgesics; Animals; Benzoxazines; Disease Models, Animal; Drug Interactions; Male; Medulla Oblongata; Morpholines; Naphthalenes; Nerve Crush; Neuralgia; Neurons; Pain Measurement; Peripheral Nervous System Diseases; Piperidines; Pyrazoles; Rats; Rats, Wistar; Reaction Time; Receptors, Cannabinoid; Receptors, Drug; Reticular Formation; Rimonabant

2001